Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin

Journal of Controlled Release

Volumn 147, Issue 3, 2010, Pages 377-384

  Sajeesh, S ^a,b   Bouchemal, K ^b   Marsaud, V ^c   Vauthier, C ^c   Sharma, Chandra P ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIV PARIS SUD   (France)

Author keywords

Cyclodextrin; Diabetes; Hydrogel; Microparticles; Oral insulin

Indexed keywords

CYCLODEXTRINS; FLUORESCENCE; GELATION; HYDROGELS; MEDICAL PROBLEMS; MONOLAYERS;

BLOOD GLUCOSE LEVEL; COMPLEX FORMATIONS; IN-VIVO EXPERIMENTS; IONIC GELATION METHOD; ISOTHERMAL TITRATION; MICRO-PARTICLES; ORAL INSULIN DELIVERY; POLY (METHACRYLIC ACID);

INSULIN;

CHITOSAN; GLUCOSE; INSULIN; MACROGOL; METHYL BETA CYCLODEXTRIN; PLACEBO; POLYMETHACRYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; ENCAPSULATION; FLUORESCENCE SPECTROSCOPY; GELATION; GLUCOSE BLOOD LEVEL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; ISOTHERMAL TITRATION CALORIMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES;

EID: 78049474668     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.08.007     Document Type: Article

References (38)

1. Loftsson T., Jarho P., Másson M., Järvinen T. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2005, 2:335-351.
2. Duchêne D., Wouessidjewe D., Ponchel G. Cyclodextrins and carrier systems. J. Control. Release 1999, 62:263-268.
3. Challa R., Abuja A., Ali J., Khar R.K. Cyclodextrins in drug delivery: an updated review. AAPS Pharm. Sci. Technol. 2005, 6:E329-E357.
4. Irie T., Uekama K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 1999, 36:101-123.
5. Carrier R.L., Miller L.A., Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J. Control. Release 2007, 123:78-99.
6. Shao Z., Li Y.P., Chermak T., Mitra A.K. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin. Pharm. Res. 1994, 11:1174-1179.
7. Agüeros M., Zabaleta V., Espuelas S., Campanero M.A., Irache J.M. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J. Control. Release 2010, 145:2-8.
8. Sajeesh S., Sharma C.P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 2006, 325:147-154.
9. Ungaro F., Villa Bianca R.E., Giovino C., Miro A., Sorrentino R., Quaglia F., La Rotond M.I. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J. Control. Release 2009, 135:25-34.
10. Agüeros M., Areses P., Campanero M.A., Salman H., Quincoces G., Peñuelas I., Irache J.M. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. Eur. J. Pharm. Sci. 2009, 37:231-240.
11. Sajeesh S., Sharma C.P. Novel polyelectrolyte complex microparticles based on poly(methacrylic acid)-2 (amino propyl) poly(ethylene glycol) for oral protein delivery. J. Biomater. Sci. Polym. Ed. 2007, 18:1125-1139.
12. Jerry N., Anitha Y., Sharma C.P., Sony P. In vivo absorption studies of insulin from an oral delivery system. Drug Deliv. 2001, 8:19-23.
13. Sajeesh S., Vauthier C., Gueutin C., Ponchel G., Sharma C.P. Thiol functionalized polymethacrylic acid based hydrogel microparticles for oral insulin delivery. Acta Biomater. 2010, 6:3072-3080.
14. Sajeesh S., Sharma C.P. Interpolymer complex microparticles based on polymethacrylic acid-chitosan for oral insulin delivery. J. Appl. Pol. Sci. 2006, 99:506-512.
15. Sajeesh S., Sharma C.P. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. J. Biomed. Mater. Res. Appl. Biomater. 2006, 76B:298-305.
16. Segura-Sanchez F., Bouchemal K., Lebas G., Vauthier C., Santos-Magalhaes N.S., Ponchel G. Elucidation of the complexation mechanism between (+)-usnic acid and cyclodextrins studied by isothermal titration calorimetry and phase-solubility diagram experiments. J. Mol. Recognit. 2009, 22:232-241.
17. Othman M., Bouchemal K., Couvreur P., Gref R. Microcalorimetric investigation on the formation of supramolecular nanoassemblies of associative polymers loaded with gadolinium chelate derivatives. Int. J. Pharm. 2009, 379:218-225.
18. Sajeesh S., Bouchemal K., Sharma C.P., Vauthier C. Surface functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery. Eur. J. Pharm. Biopharm. 2010, 74:209-218.
19. Bravo-Osuna I., Vauthier C., Chacun H., Ponchel G. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly (isobutyl cyanoacrylate) core-shell nanoparticles. Eur. J. Pharm. Biopharm. 2008, 69:436-444.
20. Rekha M.R., Sharma C.P. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J. Control. Release 2009, 135:144-151.
21. Morishita M., Goto T., Nakamura K., Lowman A.M., Takayama K., Peppas N.A. Novel oral insulin delivery systems based on complexation polymer hydrogels: Single and multiple administration studies in type 1 and 2 diabetic rats. J. Control. Release 2006, 110:587-594.
22. Frankewich R.P., Thimmaiah K.N., Hinze W.L. Evaluation of the relative effectiveness of different water-soluble beta-cyclodextrin media to function as fluorescence enhancement agents. Anal. Chem. 1991, 63:2924-2933.
23. Cox G.S., Hauptman P.J., Turro N.J. Dialkylaminobenzonitriles as fluorescence polarity probes for aqueous solutions of cyclodextrins. Photochem. Photobiol. 1984, 39:567-601.
24. Bouchemal K. New challenges for pharmaceutical formulations and drug delivery system characterization using isothermal titration calorimetry. Drug Discov. Today 2008, 13:960-972.
25. Aachmann F.L., Otzen D.E., Larsen K.L., Wimmer R. Structural background of cyclodextrin-protein interactions. Protein Eng. 2003, 16:905-912.
26. Dotsikas Y., Loukas Y.L. Kinetic degradation study of insulin complexed with methyl-beta cyclodextrin. Confirmation of complexation with electrospray mass spectrometry and 1H NMR. J. Pharm. Biomed. Anal. 2002, 29:487-494.
27. Lovatt M., Cooper A., Camilleri P. Energetics of cyclodextrin-induced dissociation of insulin. Eur. Biophys. J. 1996, 24:354-357.
28. Bibby D.C., Davies N.M., Tucker I.C. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm. 2000, 197:1-11.
29. De Rosa G., Larobina D., La Rotonda M.I., Musto P., Quaglia F., Ungar F. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-β-cyclodextrin system. J. Control. Release 2005, 102:71-83.
30. Piel G., Piette M., Barillaro V., Castagne D., Evrard B., Delattre L. Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. Int. J. Pharm. 2007, 338:35-42.
31. Kiss T., Fenyvesi F., Pasztor N., Feher P., Varadi J., Kocsan R., Szente L., Fenyvesi E., Szabo G., Vecsernyes M., Bacskay I. Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives. Pharmazie 2007, 62:557-558.
32. Bell C.L., Peppas N.A. Water, solute diffusion in physiological responsive hydrogels of poly(methacrylic acid-g-ethylene glycol). Biomaterials 1996, 17:1203-1218.
33. Dodou D., Breedveld P., Wieringa P.A. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur. J. Pharm. Biopharm. 2005, 60:1-16.
34. Madsen F., Peppas N.A. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. Biomaterials 1999, 20:1701-1708.
35. Staddon J.M., Herrenknecht K., Smales C., Rubin L.L. Evidence that tyrosine phosphorylation may increase tight junction permeability. J. Cell Sci. 1995, 108:609-619.
36. Loftsson T., Vogensen S.B., Brewster M.E., Konrasdottir F. Effects of cyclodextrin on drug delivery through biological membranes. J. Pharm. Sci. 2007, 96:2532-2546.
37. Lambert D., O'Neill C.A., Padfield P.J. Depletion of caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight junction proteins. Biochem. J. 2005, 387:553-560.
38. Stella V.J., Rao V.M., Zannou E.A., Zia V. Mechanisms of drug release from cyclodextrin complexes. Adv. Drug Deliv. Rev. 1999, 36:3-16.